9amHealth Reviews Liraglutide
Used as a genuine low-cost GLP-1 rung, which fits the generic-first protocol better than it fits most competitors' formularies.
Sold as Saxenda, Victoza · Reviewed September 19, 2026
What “Adjunct” means here
Available and used, but not the centre of the protocol — typically alongside or after another agent.
The pairing
How 9amHealth handles Liraglutide
These are the vendor-specific mechanics that determine what this molecule actually costs you and whether members stay on it long enough to benefit.
- Access status
- Adjunct
- Gating
- Within the step-therapy protocol, ahead of the weekly agents.
- Prescribes directly
- Yes
- Step therapy
- Yes
- Prior authorization
- Yes
- Titration protocol
- Generic-first protocol with documented escalation criteria to branded GLP-1s
- Off-ramp
- Pharmacist-led deprescribing review at defined intervals
- Care team
- Physicians, Nurse practitioners, Registered dietitians, Pharmacists
Ask 9amHealth this
Given generic availability, is liraglutide inside the bundled PMPM? If so, what share of members are maintained on it?
Watch out
Model the bundle against your existing PBM generic pricing. For some buyers the bundle is a premium, not a saving.
The molecule
Liraglutide in one page
The first-generation daily GLP-1. Lower efficacy than the weekly agents, but generic entry has made it the cheapest genuine GLP-1 option and a credible step-therapy rung.
Clinical profile
- Drug class
- GLP-1 receptor agonist
- Brand names
- Saxenda — Chronic weight managementVictoza — Type 2 diabetes
- Mechanism
- Single GLP-1 receptor agonist with a shorter half-life than the weekly agents, requiring daily administration to maintain effect.
- Administration
- Once-daily subcutaneous injection. Daily dosing is the main adherence disadvantage versus weekly agents.
- Titration
- Weekly dose escalation over roughly a month to the maintenance dose — a substantially shorter ladder than the weekly agents.
- Typical result
- Average body-weight reduction in the high single digits as a percentage — roughly half what the newer agents produce, though achieved faster and at a fraction of the cost.
- Generic available
- Yes
Known side effects
- Gastrointestinal effects similar in kind to the weekly agents
- Injection-site reactions somewhat more common given daily administration
- Class boxed warning regarding thyroid C-cell tumors observed in rodents
What benefits teams need to know
This is your step-therapy rung
Generic availability makes liraglutide the only GLP-1 that can sit meaningfully below the weekly agents on cost. A vendor that will genuinely trial it before escalating has a real cost-control mechanism; one that lists it and never uses it does not.
Adherence is the honest tradeoff
Daily injection produces worse persistence than weekly dosing. A step-therapy protocol built on this molecule needs to distinguish members who failed on efficacy from members who failed on adherence, because they warrant different escalation decisions.
Alternatives
Other vendors and Liraglutide
Same molecule, materially different access rules. The status column is where the cost difference lives.
| Vendor | Access | Score | PMPM |
|---|---|---|---|
| Omada Health Coaching companion | Companion support | 8.4 | $32–$58 |
| Form Health Full-service clinical | First-line | 8.0 | $58–$105 |
| Teladoc Health Navigation & orchestration | Adjunct | 7.4 | $18–$44 |
| Calibrate Full-service clinical | Adjunct | 7.2 | $65–$110 |
| Transcarent Navigation & orchestration | Orchestrated | 7.1 | $12–$32 |
| WeightWatchers Clinic Consumer-brand clinical | Adjunct | 6.9 | $30–$68 |
Same vendor
9amHealth across the formulary
How this vendor positions each molecule tells you more about its cost discipline than any single review does.
Reached only after a generic-first protocol with documented escalation criteria. Because labs and generic medications are bundled into the PMPM, 9amHealth carries real financial exposure when members escalate — a rare structural alignment.
Top of the escalation ladder, behind both generic therapy and, in most cases, semaglutide. Pharmacist-led deprescribing review at defined intervals applies here as it does across the formulary.
The default first rung and a core part of the bundle, which includes generic medications and labs in a single predictable PMPM.